|
Abrahams, B.S., and Geschwind, D.H. (2008). Advances in autism genetics: on the threshold of a new neurobiology. Nature reviews Genetics 9, 341-355.
Aldred, S., Moore, K.M., Fitzgerald, M., and Waring, R.H. (2003). Plasma amino acid levels in children with autism and their families. Journal of autism and developmental disorders 33, 93-97.
Amaral, D.G., Schumann, C.M., and Nordahl, C.W. (2008). Neuroanatomy of autism. Trends in neurosciences 31, 137-145.
American Psychiatric Association., and American Psychiatric Association. Task Force on DSM-IV. (2000). Diagnostic and statistical manual of mental disorders : DSM-IV-TR, 4th edn (Washington, DC: American Psychiatric Association).
Applegate, C.D., Frysinger, R.C., Kapp, B.S., and Gallagher, M. (1982). Multiple unit activity recorded from amygdala central nucleus during Pavlovian heart rate conditioning in rabbit. Brain Res 238, 457-462.
Aronson, M., Hagberg, B., and Gillberg, C. (1997). Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: a follow-up study. Developmental medicine and child neurology 39, 583-587.
Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal, I., Centers for Disease, C., and Prevention (2012). Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. Morbidity and mortality weekly report Surveillance summaries 61, 1-19.
Baker, D.A., Madayag, A., Kristiansen, L.V., Meador-Woodruff, J.H., Haroutunian, V., and Raju, I. (2008). Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine. Neuropsychopharmacology 33, 1760-1772.
Baker, D.A., Xi, Z.X., Shen, H., Swanson, C.J., and Kalivas, P.W. (2002). The origin and neuronal function of in vivo nonsynaptic glutamate. The Journal of neuroscience 22, 9134-9141.
Baron-Cohen, S., Ring, H.A., Bullmore, E.T., Wheelwright, S., Ashwin, C., and Williams, S.C. (2000). The amygdala theory of autism. Neurosci Biobehav Rev 24, 355-364.
Baron-Cohen, S., Ring, H.A., Wheelwright, S., Bullmore, E.T., Brammer, M.J., Simmons, A., and Williams, S.C. (1999). Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci 11, 1891-1898.
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008a). N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. Biological psychiatry 64, 361-368.
Berk, M., Copolov, D.L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., and Bush, A.I. (2008b). N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biological psychiatry 64, 468-475.
Bielsky, I.F., Hu, S.B., Szegda, K.L., Westphal, H., and Young, L.J. (2004). Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 29, 483-493.
Bobee, S., Mariette, E., Tremblay-Leveau, H., and Caston, J. (2000). Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat. Behavioural brain research 112, 107-117.
Bromley, R.L., Mawer, G., Clayton-Smith, J., and Baker, G.A. (2008). Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 71, 1923-1924.
Brothers, L., Ring, B., and Kling, A. (1990). Response of neurons in the macaque amygdala to complex social stimuli. Behav Brain Res 41, 199-213.
Buxbaum, J.D. (2009). Multiple rare variants in the etiology of autism spectrum disorders. Dialogues in clinical neuroscience 11, 35-43.
Cheng, L.L., Wang, S.J., and Gean, P.W. (1998). Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur J Neurosci 10, 2163-2172.
Choleris, E., Gustafsson, J.A., Korach, K.S., Muglia, L.J., Pfaff, D.W., and Ogawa, S. (2003). An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-alpha and -beta knockout mice. Proceedings of the National Academy of Sciences of the United States of America 100, 6192-6197.
Christensen, J., Gronborg, T.K., Sorensen, M.J., Schendel, D., Parner, E.T., Pedersen, L.H., and Vestergaard, M. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA : the journal of the American Medical Association 309, 1696-1703.
Cook, E.H., Jr. (2001). Genetics of autism. Child Adolesc Psychiatr Clin N Am 10, 333-350.
Corbett, B.A., Carmean, V., Ravizza, S., Wendelken, C., Henry, M.L., Carter, C., and Rivera, S.M. (2009). A functional and structural study of emotion and face processing in children with autism. Psychiatry research 173, 196-205.
Dalton, K.M., Nacewicz, B.M., Johnstone, T., Schaefer, H.S., Gernsbacher, M.A., Goldsmith, H.H., Alexander, A.L., and Davidson, R.J. (2005a). Gaze fixation and the neural circuitry of face processing in autism. Nature neuroscience 8, 519-526.
Dalton, K.M., Nacewicz, B.M., Johnstone, T., Schaefer, H.S., Gernsbacher, M.A., Goldsmith, H.H., Alexander, A.L., and Davidson, R.J. (2005b). Gaze fixation and the neural circuitry of face processing in autism. Nat Neurosci 8, 519-526.
Diergaarde, L., Gerrits, M.A., Brouwers, J.P., and van Ree, J.M. (2005). Early amygdala damage disrupts performance on medial prefrontal cortex-related tasks but spares spatial learning and memory in the rat. Neuroscience 130, 581-590.
DiLiberti, J.H., Farndon, P.A., Dennis, N.R., and Curry, C.J. (1984). The fetal valproate syndrome. American journal of medical genetics 19, 473-481.
Duncan, S. (2007). Teratogenesis of sodium valproate. Curr Opin Neurol 20, 175-180.
Dutta, S., Das, S., Guhathakurta, S., Sen, B., Sinha, S., Chatterjee, A., Ghosh, S., Ahmed, S., Ghosh, S., and Usha, R. (2007). Glutamate receptor 6 gene (GluR6 or GRIK2) polymorphisms in the Indian population: a genetic association study on autism spectrum disorder. Cellular and molecular neurobiology 27, 1035-1047.
Ebert, D.H., and Greenberg, M.E. (2013). Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493, 327-337.
Faiella, A., Wernig, M., Consalez, G.G., Hostick, U., Hofmann, C., Hustert, E., Boncinelli, E., Balling, R., and Nadeau, J.H. (2000). A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 9, 227-236.
Farr, S.A., Poon, H.F., Dogrukol-Ak, D., Drake, J., Banks, W.A., Eyerman, E., Butterfield, D.A., and Morley, J.E. (2003). The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Journal of neurochemistry 84, 1173-1183.
Fatemi, S.H., Halt, A.R., Stary, J.M., Kanodia, R., Schulz, S.C., and Realmuto, G.R. (2002). Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biological psychiatry 52, 805-810.
Ferguson, J.N., Young, L.J., Hearn, E.F., Matzuk, M.M., Insel, T.R., and Winslow, J.T. (2000). Social amnesia in mice lacking the oxytocin gene. Nature genetics 25, 284-288.
Flagstad, P., Mork, A., Glenthoj, B.Y., van Beek, J., Michael-Titus, A.T., and Didriksen, M. (2004). Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsychopharmacology 29, 2052-2064.
Fombonne, E. (2005). Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry 66 Suppl 10, 3-8.
Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatr Res 65, 591-598.
Geschwind, D.H. (2009). Advances in autism. Annual review of medicine 60, 367-380.
Groen, W., Teluij, M., Buitelaar, J., and Tendolkar, I. (2010). Amygdala and hippocampus enlargement during adolescence in autism. J Am Acad Child Adolesc Psychiatry 49, 552-560.
Haddad, P.M., Das, A., Ashfaq, M., and Wieck, A. (2009). A review of valproate in psychiatric practice. Expert Opin Drug Metab Toxicol 5, 539-551.
Hadjikhani, N., Joseph, R.M., Snyder, J., and Tager-Flusberg, H. (2007). Abnormal activation of the social brain during face perception in autism. Hum Brain Mapp 28, 441-449.
Hardan, A.Y., Fung, L.K., Libove, R.A., Obukhanych, T.V., Nair, S., Herzenberg, L.A., Frazier, T.W., and Tirouvanziam, R. (2012). A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biological psychiatry 71, 956-961.
Harris, S.R., MacKay, L.L., and Osborn, J.A. (1995). Autistic behaviors in offspring of mothers abusing alcohol and other drugs: a series of case reports. Alcoholism, clinical and experimental research 19, 660-665.
Hazlett, H.C., Poe, M.D., Gerig, G., Styner, M., Chappell, C., Smith, R.G., Vachet, C., and Piven, J. (2011). Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch Gen Psychiatry 68, 467-476.
Henry, T.R. (2003). The history of valproate in clinical neuroscience. Psychopharmacol Bull 37 Suppl 2, 5-16.
Hess, G., Kuhnt, U., and Voronin, L.L. (1987). Quantal analysis of paired-pulse facilitation in guinea pig hippocampal slices. Neurosci Lett 77, 187-192.
Hollander, E., Phillips, A.T., and Yeh, C.C. (2003). Targeted treatments for symptom domains in child and adolescent autism. Lancet 362, 732-734.
Hsia, A.Y., Malenka, R.C., and Nicoll, R.A. (1998). Development of excitatory circuitry in the hippocampus. J Neurophysiol 79, 2013-2024.
Hultman, C.M., Sparen, P., and Cnattingius, S. (2002). Perinatal risk factors for infantile autism. Epidemiology 13, 417-423.
Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., Gillberg, C., Leboyer, M., Bourgeron, T., and Paris Autism Research International Sibpair, S. (2002). Linkage and association of the glutamate receptor 6 gene with autism. Molecular psychiatry 7, 302-310.
Johannessen, C.U. (2000). Mechanisms of action of valproate: a commentatory. Neurochem Int 37, 103-110.
Johannessen Landmark, C. (2008). Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 22, 27-47.
Joosten, A.V., and Bundy, A.C. (2010). Sensory processing and stereotypical and repetitive behaviour in children with autism and intellectual disability. Aust Occup Ther J 57, 366-372.
Kahne, D., Tudorica, A., Borella, A., Shapiro, L., Johnstone, F., Huang, W., and Whitaker-Azmitia, P.M. (2002). Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiology ＆ behavior 75, 403-410.
Kalivas, P.W. (2009). The glutamate homeostasis hypothesis of addiction. Nature reviews Neuroscience 10, 561-572.
Kanner, L. (1968). Autistic disturbances of affective contact. Acta Paedopsychiatr 35, 100-136.
Kern, J.K., and Jones, A.M. (2006). Evidence of toxicity, oxidative stress, and neuronal insult in autism. Journal of toxicology and environmental health Part B, Critical reviews 9, 485-499.
Khan, M., Sekhon, B., Jatana, M., Giri, S., Gilg, A.G., Sekhon, C., Singh, I., and Singh, A.K. (2004). Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. Journal of neuroscience research 76, 519-527.
Kim, J.E., Lyoo, I.K., Estes, A.M., Renshaw, P.F., Shaw, D.W., Friedman, S.D., Kim, D.J., Yoon, S.J., Hwang, J., and Dager, S.R. (2010). Laterobasal amygdalar enlargement in 6- to 7-year-old children with autism spectrum disorder. Arch Gen Psychiatry 67, 1187-1197.
Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Yang, S.I., Cheong, J.H., Shin, C.Y., and Ko, K.H. (2011). The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett 201, 137-142.
Krettek, J.E., and Price, J.L. (1978). A description of the amygdaloid complex in the rat and cat with observations on intra-amygdaloid axonal connections. J Comp Neurol 178, 255-280.
Kulkarni, M.L., Zaheeruddin, M., Shenoy, N., and Vani, H.N. (2006). Fetal valproate syndrome. Indian J Pediatr 73, 937-939.
Lamb, J.A., Moore, J., Bailey, A., and Monaco, A.P. (2000). Autism: recent molecular genetic advances. Human molecular genetics 9, 861-868.
LeDoux, J. (2003). The emotional brain, fear, and the amygdala. Cellular and molecular neurobiology 23, 727-738.
Leskovec, T.J., Rowles, B.M., and Findling, R.L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harv Rev Psychiatry 16, 97-112.
Lin, H.C., Gean, P.W., Wang, C.C., Chan, Y.H., and Chen, P.S. (2013). The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model. PloS one 8, e55248.
Lin, H.C., Mao, S.C., Su, C.L., and Gean, P.W. (2010). Alterations of excitatory transmission in the lateral amygdala during expression and extinction of fear memory. Int J Neuropsychopharmacol 13, 335-345.
Linden, A.M., Greene, S.J., Bergeron, M., and Schoepp, D.D. (2004). Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 29, 502-513.
Luby, J., Mrakotsky, C., Stalets, M.M., Belden, A., Heffelfinger, A., Williams, M., and Spitznagel, E. (2006). Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. J Child Adolesc Psychopharmacol 16, 575-587.
Mineur, Y.S., Sluyter, F., de Wit, S., Oostra, B.A., and Crusio, W.E. (2002). Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 12, 39-46.
Moldrich, R.X., Chapman, A.G., De Sarro, G., and Meldrum, B.S. (2003). Glutamate metabotropic receptors as targets for drug therapy in epilepsy. European journal of pharmacology 476, 3-16.
Moles, A., Kieffer, B.L., and D'Amato, F.R. (2004). Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 304, 1983-1986.
Moreno-Fuenmayor, H., Borjas, L., Arrieta, A., Valera, V., and Socorro-Candanoza, L. (1996). Plasma excitatory amino acids in autism. Investigacion clinica 37, 113-128.
Mosconi, M.W., Cody-Hazlett, H., Poe, M.D., Gerig, G., Gimpel-Smith, R., and Piven, J. (2009). Longitudinal study of amygdala volume and joint attention in 2- to 4-year-old children with autism. Archives of general psychiatry 66, 509-516.
Muris, P., Steerneman, P., Merckelbach, H., Holdrinet, I., and Meesters, C. (1998). Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord 12, 387-393.
Myers, S.M., and Johnson, C.P. (2007). Management of children with autism spectrum disorders. Pediatrics 120, 1162-1182.
Nanson, J.L. (1992). Autism in fetal alcohol syndrome: a report of six cases. Alcoholism, clinical and experimental research 16, 558-565.
Owen, R., Sikich, L., Marcus, R.N., Corey-Lisle, P., Manos, G., McQuade, R.D., Carson, W.H., and Findling, R.L. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124, 1533-1540.
Pandina, G.J., Bossie, C.A., Youssef, E., Zhu, Y., and Dunbar, F. (2007). Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 37, 367-373.
Parachikova, A., Vasilevko, V., Cribbs, D.H., LaFerla, F.M., and Green, K.N. (2010). Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. Journal of Alzheimer's disease : JAD 21, 527-542.
Perry, W., Minassian, A., Lopez, B., Maron, L., and Lincoln, A. (2007). Sensorimotor gating deficits in adults with autism. Biol Psychiatry 61, 482-486.
Persico, A.M., and Bourgeron, T. (2006). Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29, 349-358.
Perucca, E. (2002). Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 16, 695-714.
Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G., Lazar, M.A., and Klein, P.S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. The Journal of biological chemistry 276, 36734-36741.
Purcell, A.E., Jeon, O.H., Zimmerman, A.W., Blue, M.E., and Pevsner, J. (2001). Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57, 1618-1628.
Rapin, I., and Tuchman, R.F. (2008). Autism: definition, neurobiology, screening, diagnosis. Pediatr Clin North Am 55, 1129-1146, viii.
Rasalam, A.D., Hailey, H., Williams, J.H., Moore, S.J., Turnpenny, P.D., Lloyd, D.J., and Dean, J.C. (2005). Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental medicine and child neurology 47, 551-555.
Rodier, P.M., Ingram, J.L., Tisdale, B., and Croog, V.J. (1997). Linking etiologies in humans and animal models: studies of autism. Reproductive toxicology 11, 417-422.
Rosenberg, G. (2007). The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64, 2090-2103.
Rubenstein, J.L., and Merzenich, M.M. (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes, brain, and behavior 2, 255-267.
Rutter, M. (2005). Incidence of autism spectrum disorders: changes over time and their meaning. Acta paediatrica 94, 2-15.
Schneider, M., and Koch, M. (2005). Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 30, 944-957.
Schneider, T., and Przewlocki, R. (2005). Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 30, 80-89.
Shigemoto, R., Kinoshita, A., Wada, E., Nomura, S., Ohishi, H., Takada, M., Flor, P.J., Neki, A., Abe, T., Nakanishi, S., et al. (1997). Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. The Journal of neuroscience : the official journal of the Society for Neuroscience 17, 7503-7522.
Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K.J., Sekine, Y., Suda, S., Suzuki, K., Sugihara, G., et al. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in neuro-psychopharmacology ＆ biological psychiatry 30, 1472-1477.
Sparks, B.F., Friedman, S.D., Shaw, D.W., Aylward, E.H., Echelard, D., Artru, A.A., Maravilla, K.R., Giedd, J.N., Munson, J., Dawson, G., et al. (2002). Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59, 184-192.
Stromland, K., Nordin, V., Miller, M., Akerstrom, B., and Gillberg, C. (1994). Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36, 351-356.
Su, A.I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K.A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004). A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences of the United States of America 101, 6062-6067.
Tang, E., Yip, P.K., Chapman, A.G., Jane, D.E., and Meldrum, B.S. (1997). Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats. European journal of pharmacology 327, 109-115.
Tirouvanziam, R., Obukhanych, T.V., Laval, J., Aronov, P.A., Libove, R., Banerjee, A.G., Parker, K.J., O'Hara, R., Herzenberg, L.A., Herzenberg, L.A., et al. (2012). Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders. Journal of autism and developmental disorders 42, 827-836.
Toal, F., Daly, E.M., Page, L., Deeley, Q., Hallahan, B., Bloemen, O., Cutter, W.J., Brammer, M.J., Curran, S., Robertson, D., et al. (2010). Clinical and anatomical heterogeneity in autistic spectrum disorder: a structural MRI study. Psychol Med 40, 1171-1181.
Wagner, G.C., Reuhl, K.R., Cheh, M., McRae, P., and Halladay, A.K. (2006). A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 36, 779-793.
Wall, D.P., Esteban, F.J., Deluca, T.F., Huyck, M., Monaghan, T., Velez de Mendizabal, N., Goni, J., and Kohane, I.S. (2009). Comparative analysis of neurological disorders focuses genome-wide search for autism genes. Genomics 93, 120-129.
Walsh, R.N., and Cummins, R.A. (1976). The Open-Field Test: a critical review. Psychological bulletin 83, 482-504.
Wang, A.T., Dapretto, M., Hariri, A.R., Sigman, M., and Bookheimer, S.Y. (2004). Neural correlates of facial affect processing in children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 43, 481-490.
Webb, S.J., Sparks, B.F., Friedman, S.D., Shaw, D.W., Giedd, J., Dawson, G., and Dager, S.R. (2009). Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res 172, 61-67.
Wieronska, J.M., Szewczyk, B., Palucha, A., Branski, P., Zieba, B., and Smialowska, M. (2005). Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala. Pharmacological reports : PR 57, 734-743.
Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B., and Hersh, J.H. (2001). Fetal valproate syndrome and autism: additional evidence of an association. Developmental medicine and child neurology 43, 202-206.
Winslow, J.T., Hearn, E.F., Ferguson, J., Young, L.J., Matzuk, M.M., and Insel, T.R. (2000). Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Hormones and behavior 37, 145-155.
Wyszynski, D.F., Nambisan, M., Surve, T., Alsdorf, R.M., Smith, C.R., Holmes, L.B., and Antiepileptic Drug Pregnancy, R. (2005). Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64, 961-965.
Yizhar, O., Fenno, L.E., Prigge, M., Schneider, F., Davidson, T.J., O'Shea, D.J., Sohal, V.S., Goshen, I., Finkelstein, J., Paz, J.T., et al. (2011). Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171-178.
Zanchi, A.C., Saiki, M., Saldiva, P.H., Barros, H.M., and Rhoden, C.R. (2010). Hippocampus lipid peroxidation induced by residual oil fly ash intranasal instillation versus habituation to the open field. Inhalation toxicology 22, 84-88.
Zucker, R.S., and Regehr, W.G. (2002). Short-term synaptic plasticity. Annu Rev Physiol 64, 355-405.
|